The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 5
- 5 renewals
- Median first-year cost
- $1,266,184
- $6,286,477 in all
- Institutions
- 5
- 5 contact PIs
- Patents
- 23
- from 2 funded projects
Awards by fiscal year
Fiscal years 2014 to 2026.
Most frequent institutions
- CINCINNATI CHILDRENS HOSP MED CTR1
- DARTMOUTH COLLEGE1
- SEATTLE CHILDREN'S HOSPITAL1
- UNIV OF NORTH CAROLINA CHAPEL HILL1
- UNIVERSITY OF IOWA1
Most frequent study sections
- Special Emphasis Panel (ZDK1 GRB-M (J1))5
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2025 | Center for Cystic Fibrosis Translational Research in the Post-CFTR modulator Era2P30DK089507-16 | Goss, Christopher HooperHoffman, Lucas R | SEATTLE CHILDREN'S HOSPITAL, WA | First-year cost $1,313,622 | Study section ZDK1 |
| FY2025 | DartCF: The Dartmouth Cystic Fibrosis Research Center2P30DK117469-08 | Madden, Dean R | DARTMOUTH COLLEGE, NH | First-year cost $1,291,515 | Study section ZDK1 |
| FY2025 | UNC Cystic Fibrosis Research and Translation Core Center2P30DK065988-21 | Boucher, Richard CharlesGentzsch, MartinaO'Neal, Wanda K | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | First-year cost $1,266,184 | Study section ZDK1 |
| FY2025 | Personalized Cystic Fibrosis Therapy and Research Center2P30DK117467-08 | Amin, Raouf S.Helmrath, Michael A.Naren, Anjaparavanda P | CINCINNATI CHILDRENS HOSP MED CTR, OH | First-year cost $1,248,906 | Study section ZDK1 |
| FY2025 | Precision Medicine Center for Cystic Fibrosis2P30DK054759-26 | Ryan, Amy Leanne | UNIVERSITY OF IOWA, IA | First-year cost $1,166,250 | Study section ZDK1 |
Patents from its funded projects
23 patents name 2 of the 5 funded projects. The newest 5, by patent number.
- US 11,357,758 (opens the patent at USPTO, a PDF, in a new tab)EPITHELIAL CELL SPHEROIDS AND METHODS OF MAKING AND USING THE SAMEGranted June 14, 2022 to THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILLP30DK065988 · UNIV OF NORTH CAROLINA CHAPEL HILL, NC
- US 10,093,927 (opens the patent at USPTO, a PDF, in a new tab)RNA Interference SupressionGranted October 9, 2018 to University of Iowa Research FoundationP30DK054759 · UNIVERSITY OF IOWA, IA
- US 10,072,264 (opens the patent at USPTO, a PDF, in a new tab)Allele-Specific Silencing of Genes With siRNA for Therapeutic PurposesGranted September 11, 2018 to University of Iowa Research FoundationP30DK054759 · UNIVERSITY OF IOWA, IA
- US 9,650,631 (opens the patent at USPTO, a PDF, in a new tab)Reduction of Off-Target RNA Interference ToxicityGranted May 16, 2017 to University of Iowa Research FoundationP30DK054759 · UNIVERSITY OF IOWA, IA
- US 9,523,093 (opens the patent at USPTO, a PDF, in a new tab)Huntington's Disease Therapeutic CompoundsGranted December 20, 2016 to University of Iowa Research FoundationP30DK054759 · UNIVERSITY OF IOWA, IA
Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.
Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-12-0.3.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.